138 related articles for article (PubMed ID: 11075993)
1. Cholecystokinin does not affect the pancreatic contents of epidermal growth factor or its receptor.
Ohlsson B; Rehfeld JF; Sundler F
Pancreas; 2000 Nov; 21(4):385-91. PubMed ID: 11075993
[TBL] [Abstract][Full Text] [Related]
2. The method of administration of cholecystokinin determines the effects evoked in the pancreas.
Ohlsson B; Borg K; Rehfeld JF; Axelson J; Sundler F
Pancreas; 2001 Jul; 23(1):94-101. PubMed ID: 11451154
[TBL] [Abstract][Full Text] [Related]
3. Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreas.
Ohlsson B; Borg K; Mulder H; Rehfeld JF; Axelson J; Sundler F
Scand J Gastroenterol; 2000 Jun; 35(6):612-8. PubMed ID: 10912661
[TBL] [Abstract][Full Text] [Related]
4. The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas.
Ohlsson B; Borg K; Rehfeld JF; Ihse I; Axelson J
Int J Pancreatol; 1998 Dec; 24(3):211-8. PubMed ID: 9873956
[TBL] [Abstract][Full Text] [Related]
5. The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin.
Axelson J; Fan BG; Ohlsson B; Rehfeld J; Ekelund M; Ihse I
Int J Pancreatol; 1996 Oct; 20(2):109-18. PubMed ID: 8968866
[TBL] [Abstract][Full Text] [Related]
6. Portacaval shunt increases the trophic effect of cholecystokinin on the rat pancreas.
Nylander AG; Chen D; Rehfeld JF; Håkanson R
Scand J Gastroenterol; 1993 Feb; 28(2):145-8. PubMed ID: 8441908
[TBL] [Abstract][Full Text] [Related]
7. Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas.
Fan BG; Axelson J; Sternby B; Rehfeld J; Ihse I; Ekelund M
Scand J Gastroenterol; 1997 Apr; 32(4):380-6. PubMed ID: 9140162
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of cholecystokinin-A receptor mRNA in pancreas and cholecystokinin-B receptor mRNA in oxyntic mucosa after porta-caval shunting in rats.
Nylander AG; von Friesen CP; Monstein HJ; Yamada H; Chen D; Boketoft A; Håkanson R
Pharmacol Toxicol; 1997 Mar; 80(3):147-51. PubMed ID: 9101588
[TBL] [Abstract][Full Text] [Related]
9. The trophic response of rat pancreas to sulfated cholecystokinin-8 is dose- and time-dependent and not affected by vagotomy or atropine.
Nylander AG; Chen D; Ding XQ; Norlén P; Håkanson R
Pharmacol Toxicol; 1997 Mar; 80(3):142-6. PubMed ID: 9101587
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-alpha and epidermal growth factor expression in the exocrine pancreas of azaserine-treated rats: modulation by cholecystokinin or a low fat, high fiber (caloric restricted) diet.
Visser CJ; Woutersen RA; Bruggink AH; van Garderen-Hoetmer A; Seifert-Bock I; Tilanus MG; de Weger RA
Carcinogenesis; 1995 Sep; 16(9):2075-82. PubMed ID: 7554057
[TBL] [Abstract][Full Text] [Related]
11. CCK stimulates growth of both the pancreas and the liver.
Ohlsson B; Rehfeld JF; Axelson J
Int J Surg Investig; 1999; 1(1):47-54. PubMed ID: 11817337
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of the influence of devazepide and CCK-8S on the intact and resected rat liver.
Ohlsson B; Rehfeld JF; Axelson J
Eur Surg Res; 1998; 30(6):378-84. PubMed ID: 9838229
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin and EGF activate a MAPK cascade by different mechanisms in rat pancreatic acinar cells.
Dabrowski A; Groblewski GE; Schäfer C; Guan KL; Williams JA
Am J Physiol; 1997 Nov; 273(5):C1472-9. PubMed ID: 9374631
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of a long-acting somatostatin analogue on EGF-stimulated cell proliferation in Capan-2 cells.
Burghardt B; Barabás K; Marcsek Z; Flautner L; Gress TM; Varga G
J Physiol Paris; 2000; 94(1):57-62. PubMed ID: 10761690
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor activates several transduction pathways in rat pancreatic acini.
Aparicio IM; Garcia-Marin LJ; Andreolotti AG; Bodega G; Jensen RT; Bragado MJ
Biochim Biophys Acta; 2003 Dec; 1643(1-3):37-46. PubMed ID: 14654226
[TBL] [Abstract][Full Text] [Related]
16. The effect of concomitant stimulation with cholecystokinin and epidermal growth factor on extracellular signal-regulated kinase (ERK) activity in pancreatic acinar cells.
Daniluk J; Dabrowski A
J Physiol Pharmacol; 2007 Sep; 58(3):441-53. PubMed ID: 17928641
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of transforming growth factor-alpha and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters.
Visser CJ; Bruggink AH; Korc M; Kobrin MS; de Weger RA; Seifert-Bock I; van Blokland WT; van Garderen-Hoetmer A; Woutersen RA
Carcinogenesis; 1996 Apr; 17(4):779-85. PubMed ID: 8625491
[TBL] [Abstract][Full Text] [Related]
18. Enterochromaffin-like cells in rat stomach respond to short-term infusion of high doses of cholecystokinin but not to long-term, sustained, moderate hyperCCKemia caused by continuous cholecystokinin infusion or pancreaticobiliary diversion.
Nylander AG; Chen D; Lilja I; Axelson J; Ihse I; Rehfeld JF; Sundler F; Håkanson R
Scand J Gastroenterol; 1993 Jan; 28(1):73-9. PubMed ID: 8430275
[TBL] [Abstract][Full Text] [Related]
19. Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor.
Ohlsson B; Axelson J; Sternby B; Rehfeld JF; Ihse I
Int J Pancreatol; 1995 Aug; 18(1):59-66. PubMed ID: 7594771
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic growth after pancreatico-biliary diversion does not increase the capacity to secrete amylase.
Axelson J; Jansen C; Sternby B; Björkman A; Rehfeld JF; Ihse I
Eur Surg Res; 1999; 31(2):187-95. PubMed ID: 10213858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
